Childs John W's Form 4 filing
Veradermics, Inc (MANE) · filed Feb 5, 2026
- Accession no.
- 0001628280-26-005906
- Filed
- Feb 5, 2026
- Trade date
- Feb 3-5, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market purchases total $5.00M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001027035-26-000004 (Feb 27, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Childs John WCIK 0001027035 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Common Stock | CConversionAcquired | +480,269 | – | – | 480,269 | Indirect | |
| Feb 5, 2026 | Common Stock | CConversionAcquired | +906,862 | – | – | 1,387,131 | Indirect | |
| Feb 5, 2026 | Common Stock | CConversionAcquired | +520,758 | – | – | 1,907,889 | Indirect | |
| Feb 5, 2026 | Common Stock | PPurchaseAcquired | +294,117 | $17.00 | +$4,999,989 | 2,202,006 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Common Stock | CConversionDisposed | −480,269 | – | – | 0 | Indirect | |
| Feb 5, 2026 | Common Stock | CConversionDisposed | −906,862 | – | – | 0 | Indirect | |
| Feb 5, 2026 | Common Stock | CConversionDisposed | −520,758 | – | – | 0 | Indirect | |
| Feb 3, 2026 | Common Stock | AGrant or awardAcquired | +51,525 | $0.00 | $0 | 51,525 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.